

| Revenue | $10 - $100 million See Exact Annual Revenue |
|---|---|
| Employees | 10 - 100Exact Company Size |
| Primary Industry | 325411 Medicinal & Botanical Manufacturing |
| Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing |
| Address | 230 Park Ave Fl 33 Ste 3350 New York, NY 10169 |
| Y-Mabs Therapeutics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $10 - $100 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Y-Mabs Therapeutics P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| Y-LABS Research and development services in the field of antibodies; Research and development services in the field of antibody technology; Laboratory research and analysis in the field of the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of oncology, chemotherapy, and inflammatory diseases; Industrial analysis and research services in the field of chemistry | 08/29/2023 |
| SADA Y-PRIT Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer | 06/08/2023 |
| Y-MABS CONNECT Providing consulting in the field of healthcare insurance benefits; providing insurance information about healthcare insurance plans, patient financial assistance and patient reimbursement programs; providing insurance information in the field of medication insurance coverage, reimbursement, payer policies, and patient financial assistance for healthcare providers and patients; healthcare insurance services, namely, benefit verification services | 06/23/2020 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| XYMOGEN | Orlando, FL | 100 |
| AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
| NUTRITION FORMULATORS | Miramar, FL | 36 |
| RTPR | Cabot, AR | 33 |
| INTEGRATED BOTANICS | Fort Worth, TX | 29 |
| COSMAX NBT USA | Garland, TX | 29 |
| CJB INDUSTRIES | Valdosta, GA | 28 |
| ALTERNATIVE LABORATORIES | Naples, FL | 28 |
| S&B PHARMA | Azusa, CA | 28 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| CURALEAF | New York, NY | 100 |
| Y-MABS THERAPEUTICS | New York, NY | 0 |
| INVENTIVA | New York, NY | 0 |
| NEURVATI NEUROSCIENCES | New York, NY | 0 |
| LESCARDEN | New York, NY | 0 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |